Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-centeR, Randomized, DoUBle-Masked, Placebo-Controlled StudY to Evaluate the Clinical Safety and Efficacy of OKG-0301 in the Treatment of Acute Adenoviral Conjunctivitis

NCT03856645 is registered in ClinicalTrials.gov with Okogen as lead sponsor.

NCT NCT03856645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-centeR, Randomized, DoUBle-Masked, Placebo-Controlled StudY to Evaluate the Clinical Safety and Efficacy of OKG-0301 in the Treatment of Acute Adenoviral Conjunctivitis
Lead sponsor
Okogen
Phase
Phase 2
Overall status
Unknown status
Start date
February 11, 2019
Completion date
June 30, 2022
Enrollment
219 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adenoviral conjunctivitis